Public Health Agency of Canada
Symbol of the Government of Canada
Skip to content | Skip to institutional links

Common menu bar links

Home > Infectious Diseases > National Microbiology Laboratory > Enterics & Bacteriology > Nosocomial and Antimicrobial Resistance > Publications

Institutional links

Search Box

 

 

National Microbiology Laboratory

List of Publications

Publications (Peer Reviewed Since 2000):

  1. Pitout, JD. DL Church, DB Gregson, M. McCracken, MR Mulvey, and KB Laupland. 2007. Molecular Epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: The Emergence of CTX-M-15. Antimicrobial Agents and Chemotherapy. In press.
  1. DM. Tracz, DA. Boyd, R. Hizon, E. Bryce, A. McGeer, M. Ofner-Agostini, A.E. Simor, S. Paton, MR. Mulvey. 2007. ampC gene expression in promoter mutants of cefoxitin resistant Escherichia coli clinical isolates. FEMS Microbiology Letters. In press.
  1. Amiali, N. M., M. R. Mulvey, J. Sedman, A. E. Simor, A. A. Ismail. 2007. Epidemiological typing of methicillin-resistant Staphylococcus aureus by Fourier Transform Infrared Spectroscopy. Journal of Microbiological Methods. In press.
  1. Doublet B., G. Golding, M. R. Mulvey, and A. Cloeckaert. 2007. Potential integration sites of the Salmonella genomic island 1 in Proteus mirabilis and other bacteria.  Journal of Antimicrobial Chemotherapy. In press

  2. Philippe R.S. Lagacé-Wiens, Kim A. Nichol, Lindsay E. Nicolle, Mel DeCorby, Melissa McCracken, Michelle J. Alfa, Michael R. Mulvey and George G. Zhanel.  Characterization of Fluoroquinolone and Multi-Drug Resistant Extended Spectrum -Lactamase (ESBL) Producing Escherichia coli in Manitoba.  The Canadian Journal of Infectious Diseases and Medical Microbiology. In press.

  3. Amiali, N. M., M. R. Mulvey, J. Sedman, M. Louie, A. E. Simor, A. A. Ismail. 2006. Rapid Identification of Coagulase Negative Staphylococci by Fourier Transform Infrared Spectroscopy. Journal of Microbiological Methods. In press.
  1. Embil, J.M, Z.J. Oliver, M.R. Mulvey, and E. Trepman.. A man with recurrent furunculosis. Canadian Medical Association Journal. In press.
  1. Gilbert M, J. Macdonald, D. Gregson, J. Siushansian, K. Zhang, S. Elsayed, K. Laupland, T. Louie, K. Hope, M. Mulvey, J. Gillespie, D. Nielsen, V. Wheeler, M. Louie, A. Honish, G. Keays, J. Conly..  2006. Outbreak in Alberta of community--acquired (USA300) methicillin--resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration. Canadian Medical Association Journal. 175:149-154.
  1. Boyd, DA, and MR Mulvey. Oxa-1 is Oxa-30 is Oxa-1. .2006.  Journal of Antimicrobial Chemotherapy. Letter to the Editor 58:224-225.
  1. Mulvey, MR, D.A. Boyd, A.B. Olson, B. Doublet, A. Cloeckaert. 2006. The genetics of Salmonella genomic island 1, Microbes Infect. 8: 1915-1922.
  1. Arlet, G., T.J. Barrett, P. Butaye, A. Cloeckaert, M.R. Mulvey, D.G. White. 2006. Salmonella resistant to extended-spectrum cephalosporins: prevalence, and epidemiology, Microbes Infect. 8:1945-1954.
  1. Zhanel, G. G., X. Wang, K. Nichol, A. Nikulin, A. Wierzbowski, M. Mulvey, and D. J. Hoban.  2006.  Molecular characterization of Canadian multi-drug resistant Streptococcus pneumoniae from 1998-2004.  International Journal of Antimicrobial Agents
  1. Boyd, DA, T. Du, R. Hizon, B. Kaplen, T. Murphy, S. Tyler, S. Brown, F. Jamieson,  K. Weiss, MR. Mulvey, and the Canadian Nosocomial Infection Surveillance Program. 2006.  VanG-type vancomycin resistant Enterococcus faecalis isolated in Canada. Antimicrobial Agents and Chemotherapy. 50:2217-2221.
  1. Lagacé-Wiens, P., K. Nichol, L. Nicolle, M. DeCorby, M. McCracken, M. Mulvey, G.G. Zhanel. 2006.  Treatment of Lower Urinary Tract Infection Caused by Multi-drug Resistant Extended Spectrum beta-Lactamase Producing Escherichia coli with Amoxicillin-Clavulanate: Case report and characterization of the isolate. Journal of Antimicrobial Chemotherapy. 57:1262-1263.
  1. Stratilo CW, C. Lewis, L. Bryden, M. R. Mulvey, D. Bader. 2006. Identification of Bacillus anthracis isolates using single nucleotide repeat analysis (SNRA). Journal of Clinical Microbiology, 44:777-782.
  1. Boyd, DA, M. A. Miller, and M. R. Mulvey. 2006. E. gallinarum N04-0414 harbors a VanD-type vancomycin resistance operon and does not contain a D-alanine:D-alanine 2 (ddl2) gene. Antimicrobial Agents and Chemotherapy. 50:1067-1070
  1. Ofner-Agostini M., A. E. Simor, M. Mulvey, E. Bryce, M. Loeb, A. McGeer, A. Kiss, S. Paton,  and the Canadian Nosocomial Infection Surveillance Program, Health Canada. 2006. Methicillin-Resistant Staphylococcus aureus (MRSA) in Canadian Aboriginal People.  Infection Control and Hospital Epidemiology. 27:204-207.
  1. McDonald RM, N.A. Antonishyn, T. Hansen, L.A. Snook, E. Nagle, M. R. Mulvey, P.N. Levett, and G.B. Horsman. 2005. Development of a triplex real-time PCR assay for the detection of Panton-Valentine leukocidin toxin genes in clinical isolates of methicillin-resistant Staphylococcus aureus. Journal of Clinical Microbiology. 43:6147-6149.
  1. Simor A. E., M. Ofner-Agostini, S. Paton, A. McGeer, M. Loeb, E. Bryce, M. Mulvey, and the Canadian Nosocomial Infection Surveillance Program (CNISP). 2005. Clinical and Epidemiologic Features of Methicillin-Resistant Staphylococcus aureus (MRSA) in Hospitalized Elderly Adults.  Infection Control and Hospital Epidemiology. 26:838-841.
  1. Wierzbowski AK,  D. Boyd, M. Mulvey, DJ Hoban, GG Zhanel. 2005. Expression of the mef(E) gene encoding the macrolide efflux pump protein increases in Streptococcus pneumoniae with increasing resistance to macrolides.
    Antimicrobial Agents and Chemotherapy 49::4635-40.
  1. Mulvey, M. R., L. MacDougall, B. Cholin, G. Horsman, M. Fidyk, and S. Woods, and the Saskatchewan CA-MRSA Study Group. 2005. Emergence of the USA400 Clone of Community-Associated Methicillin Resistant Staphylococcus aureus in Canada. Emerging and Infectious Diseases. 11:844-850.
  1. Olson, A. B, M.  Silverman, D. A. Boyd, A. McGeer, B. M. Willey, V. Pong-Porter, N. Daneman, and M. R. Mulvey. 2005. Identification of a progenitor of the CTX-M-9 group of extended-spectrum ß-lactamases from Kluyvera georgiana isolated in Guyana. Antimicrobial Agents and Chemotherapy. 49:2112-2115.

  2. Doublet D., D. Boyd, M. R. Mulvey, and A. Cloeckaert. 2005. The Salmonella genomic island 1 is an integrative mobilizable element.  Molecular Microbiology. 55:1911-1924.
  1. Tracz, D. M., D. A. Boyd, L Bryden, R. Hizon, S. Giercke, P. Van Caeseele, M. R. Mulvey. 2005. Increase in ampC promoter strength due to mutations and deletion of the attenuator in a clinical isolate of cefoxitin-resistant Escherichia coli as determined by RT-PCR. Journal Antimicrobial Chemotherapy. 55:768-772.

  2. Wierzbowski, A. K., D. Swedlo, D. Boyd, M. R. Mulvey, K. A Nichol, D. J Hoban, G. G Zhanel. 2005. Molecular Epidemiology and Prevalence of Macrolide Efflux Genes mef(A) and mef(E) in Streptococcus pneumoniae Obtained in Canada from 1997 to 2002.  Antimicrobial Agents and Chemotherapy. 49:1257-1261.

  3. Mulvey, M. R., E. Bryce, D. A. Boyd, M. Ofner-Agostini, A. M. Land, A. E. Simor, S. Paton, The Canadian Hospital Epidemiology Committee, and The Canadian Nosocomial Infection Surveillance Program, Health Canada. 2005. Molecular Characterization of Cefoxitin Resistant Escherichia coli from Canadian Hospitals. Antimicrobial Agents and Chemotherapy. 49:358-365.

  4. Munday C. J, D. A. Boyd, N. Brenwald, M. Miller, J. M. Andrews, R. Wise, M. R. Mulvey, P. M. Hawkey. 2004. Molecular and Kinetic Comparison of the Novel Extended-Spectrum {beta}-Lactamases CTX-M-25 and CTX-M-26. Antimicrobial Agents Chemotherapy. 48:4829-4834.

  5. Boyd, D. A., S. Tyler, S. Christianson, A. McGeer, M. P. Muller, B. M. Willey, E. Bryce, M. Gardam, P. Nordmann, M. R. Mulvey. and the Canadian Nosocomial Infection Surveillance Program, Health Canada.  2004.  Complete Nucleotide Sequence of a 92-kb Plasmid Harboring the Extended Spectrum Beta-Lactamase CTX-M-15 Involved in a Long-term Care Outbreak in Toronto. Antimicrobial Agents and Chemotherapy. 48:3758-3764.

  6. Baucheron S., S. Tyler, D. Boyd, M. R. Mulvey, E. Chaslus-Dancla, A. Cloeckaert .  2004. AcrAB-TolC directs efflux-mediated multidrug resistance in Salmonella enterica serovar typhimurium DT104 Antimicrob Agents Chemother. 48:3729-3735.

  7. Boyd, D., P. Kibsey, D. Roscoe, M. R. Mulvey and the Canadian Nosocomial Infection Surveillance Program (CNISP). 2004.  Enterococcus faecium N03-0072 carries a new VanD-type vancomycin resistance; characterization of the vanD5 operon.  Journal of Antimicrobial Chemotherapy. 54:680-683.

  8. Mulvey, M. R., D. Boyd, A. Cloeckaert, R. Ahmed and L-K Ng, and the Canadian Public Health Laboratories. 2004.  A dramatic increase of Salmonella enterica Serovar Paratyphi B dT+ harboring the antibiotic resistant Salmonella Genomic Island 1 in Canada in 2001-2002. Emerging Infectious Diseases. 10:1307-1310.

  9. Doublet, B., P. Butaye, H. Imberechts, D. Boyd, M. R. Mulvey, E. Chaslus-Dancla, and A. Cloeckaert.  2004.  Characterization of Salmonella genomic island 1 multidrug resistance gene clusters from S. enterica serovar Agona, Belgium, 1992-2002. Antimicrob. Agents Chemother. 48:2510-2517.

  10. Hutchinson, J., W. Runge, M. R. Mulvey, G. Norris,  M. Yetman, F. Lepine, N. Valkova. 2004. Burkholderia cepacia Infections Associated with Intrinsically Contaminated Ultrasound Gel - the Role of Microbial Degradation of Parabens. Infection Control and Hospital Epidemiology. 25:291-296

  11. Mulvey, M. R., D.A. Boyd, L. Baker, O. Mykytczuk, E. M. Reis, M. D. Asensi, D. P. Rodrigues, L-K. Ng. 2004. Characterization of a Salmonella enterica serovar Agona strain harbouring a class 1 integron containing novel OXA-type {beta}-lactamase (blaOXA-53) and 6'-N-aminoglycoside acetyltransferase genes [aac(6')-I30]. J. Antimicrob.Chemother. 54: 354-59.

  12. Mulvey, M. R., E. Bryce, D. Boyd, M. Ofner-Agostini, S. Christianson, A. E. Simor, S. Paton, The Canadian Hospital Epidemiology Committee, and The Canadian Nosocomial Infection Surveillance Program, Health Canada.  2004. Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals.  Antimicrobial Agents and Chemotherapy. 48:1204-1214.

  13. Mulvey, M. R., D. Boyd, L-K. Ng, S. Brown, M. Lombos, B. Ciebin, A. Li, and F. Jamieson. 2004. Characterization of the first Salmonella enterica serovar Typhi harbouring an integron in Canada. Antimicrobial Agents and Chemotherapy. 48: 689-690.

  14. Pitout, J. D. D.,  M. D. Reisbig, M. R. Mulvey, L. Chui, M. Louie, L. Crowe, D. L. Church, S. Elsayed, D. Gregson, R. Ahmed, P. Tilley and N. D. Hanson. 2003.. Association between the Handling of Pet Treats and Infection with Salmonella enterica serotype Newport expressing the AmpC b-lactamase, CMY-2.  Journal of Clinical Microbiology. 41:4578-4582.

  15. Doublet, B., R. Lailler, D. Meunier, A. Brisabois, D. Boyd, M. R. Mulvey, E. Chaslus-Dancla, and A. Cloeckaert. 2003. Identification of a variant Salmonella genomic island I antibiotic resistance gene cluster in Salmonella enterica serovar Albany.  Emerging Infectious Diseases. 9:585-591

  16. Mulvey, M. R., G. Soule, D. Boyd, W. Demczuk, R. Ahmed, and the Multi-provincial Salmonella Typhimurium Case Control Study Group. 2003. Characterization of the First Extended-Spectrum Beta-Lactamase Producing Salmonella Isolated in Canada. Journal of Clinical Microbiology 41:460-462.

  17. Simor, A. E., M. Ofner-Agostini, E. Bryce, A. McGeer, S. Paton, M. R. Mulvey, and The Canadian Nosocomial Infection Surveillance Program, Health Canada. 2002.  Laboratory Characterization of Methicillin-Resistant Staphylococcus aureus in Canadian Hospitals: The Results of Five Years of National Surveillance 1995-1999.  Journal of Infectious Diseases. 186:652-660.

  18. Boyd, D., T. Cabral, P. Van Caeseele, J. Wylie, and M.R. Mulvey. 2002.  Molecular characterization of the vanE gene cluster in vancomycin-resistant Enterococcus faecalis N00-410 isolated in Canada.  Antimicrobial Agents and Chemotherapy. 46:1977-1979.

  19. Boyd, D., A. Cloeckaert, E. Chaslus-Dancla, and M. R. Mulvey.  2002.  Characterization of Variant Salmonella Genomic Island 1 Multidrug Resistance Regions from Serovars Typhimurium DT104 and Agona.  Antimicrobial Agents and Chemotherapy.  46:1714-1722.

  20. Meunier, D., D. Boyd, M. R. Mulvey, S. Baucheron,C. Mammina, A. Nastasi, E. Chaslus-Dancla, and A Cloeckaert. 2002  Salmonella enterica Serovar Typhimurium DT104 antibiotic resistance Genomic Island I in S. enterica Serovar Paratyphi B.  Emerging Infectious Diseases.  8:430-433.

  21. Boyd, D., G. Peters, A. Cloeckaert, K. Boumedine, E. Chaslus-Dancla, H. Imberechts, and M. Mulvey. 2001.  Complete nucleotide sequence of a 43 kb genomic island associated with the multidrug resistance region of Salmonella enterica Typhimurium DT104 and its identification in phage type DT120 and serovar Agona.  Journal of Bacteriology. 183:5725-5732.

  22. Conly, J., M. Ofner-Agostini, S. Paton, L. Johnston, M. R. Mulvey, A. Kureishi, L. Nicholle, A. Matlow, The Canadian Epidimiology Committee, and The Canadian Nosocomial Infection Surveillance Program. 2001.  The emerging epidemiology of vancomycin-resistance in Canada: Results of the Canadian Nosocomial Infection Surveillance Program Passive Reporting Network 1994-1998.  The Canadian Journal of Infection Control. 16:71-80.

  23. Mulvey, M. R, L. Chui, J. Ismaïl, L. Louie, C. Murphy, N. Chang, M. Alfa, and Canadian Committee for the Standardization of Molecular Methods.  2001.Development of a Canadian Standardized Protocol for Subtyping Methicillin-Resistant Staphylococcus aureus Using Pulsed-Field Gel Electrophoresis.  Journal of Clinical Microbiology. 39:3481-3485.

  24. Simor, A. E., M. Ofner-Agostini, E. Bryce, K. Green, A. McGeer, M. R. Mulvey, S. Paton and the Canadian Nosocomial Infection Surveillance Program. 2001. The evolution of methicillin-resistant Staphylococcus aureus in Canadian Hospitals: Five Years of National Surveillance. Canadian Medical Association Journal. 165:21-26.

  25. Elsayed, S., N. Hamilton, D. Boyd, and M. R. Mulvey. 2001. Improved primer design for multiplex PCR analysis of vancomycin-resistant Enterococcus spp. Journal of Clinical Microbiology 39:2367-2368.

  26. Ng, L-K, I. Martin, M. Alfa, M. R. Mulvey. 2001. Multiplex PCR for the detection of tetracycline resistant genes. Molecular and Cellular Probes. 15:209-215.

  27. Hyland, M, M. Ofner-Agostini, M. Miller, S. Paton, M. Gourdeau, M, Ishak, the Canadian Hospital Epidemiology Committee, and the Canadian Nosocomial Infection Surveillance Program, Health Canada. 2001. Nosocomial Clostridium difficile- associated diarrhea (N-CDAD) in Canada- The results of the Canadian Nosocomial Infection Surveillance Program (CNISP) 1997 N-CDAD prevalence surveillance project. Canadian Journal of Infectious Diseases. 12:81-88.

  28. Cayouette, M, L. P. Jette, and M. R. Mulvey. 2001. Extended-spectrum beta-lactamases (ESBL) at CHRDL: Seek and you will find. Association des Medecins Microbiologistes-Infectiologues du Quebec (AMMIQale) 9:41-46.

  29. Boyd, D A., J. Conly, H. Dedier, G. Peters, L. Robertson, E. Slater, and M. R. Mulvey. 2000. Molecular characterization of the vanD gene cluster and a novel insertion element in a vancomycin-resistant Enterococus isolated in Canada.  Journal of Clinical Microbiology 38:2392-2394.

  30. Boyd, D A., G. A. Peters, L-K. Ng, and M. R. Mulvey. 2000. Partial characterization of a genomic island associated with the multidrug resistance region of Salmonella enterica Typhimurium DT104.FEMS Microbiology Letters. 189:285-291.

  

Date Modified: 2006-12-15

Top of Page
Important Notices